Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2013 1
2015 2
2018 1
2019 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Loop-mediated isothermal amplification of DNA.
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Notomi T, et al. Among authors: masubuchi h. Nucleic Acids Res. 2000 Jun 15;28(12):E63. doi: 10.1093/nar/28.12.e63. Nucleic Acids Res. 2000. PMID: 10871386 Free PMC article.
Immunoglobulin G4-related lung disease: clinicoradiological and pathological features.
Matsui S, Hebisawa A, Sakai F, Yamamoto H, Terasaki Y, Kurihara Y, Waseda Y, Kawamura T, Miyashita T, Inoue H, Hata N, Masubuchi H, Sugino K, Kishi J, Kobayashi H, Usui Y, Komazaki Y, Kawabata Y, Ogura T. Matsui S, et al. Among authors: masubuchi h. Respirology. 2013 Apr;18(3):480-7. doi: 10.1111/resp.12016. Respirology. 2013. PMID: 23145930
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.
Kanbe M, Sunaga N, Hara K, Sawada H, Wakamatsu I, Hara K, Muto S, Sawada Y, Masubuchi H, Sato M, Miura Y, Tsurumaki H, Yatomi M, Sakurai R, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T. Kanbe M, et al. Among authors: masubuchi h. Thorac Cancer. 2022 Nov;13(22):3225-3228. doi: 10.1111/1759-7714.14678. Epub 2022 Oct 4. Thorac Cancer. 2022. PMID: 36193787 Free PMC article.
Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
Takemura M, Motegi M, Kuroiwa Y, Itai M, Taguchi K, Umetsu K, Uchida M, Kounoc S, Sato M, Masubuchi H, Yamaguchi A, Yamaguchi K, Ikeda K, Nakagawa J, Maeno T. Takemura M, et al. Among authors: masubuchi h. Respir Med Case Rep. 2021 Feb 2;32:101361. doi: 10.1016/j.rmcr.2021.101361. eCollection 2021. Respir Med Case Rep. 2021. PMID: 33643837 Free PMC article.
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M. Yamaguchi K, et al. Among authors: masubuchi h. Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22. Respir Med. 2018. PMID: 29957268 Free article.
A case of Trousseau syndrome caused by pulmonary adenocarcinoma that was controlled for one year and 10 months with thrombosis treatment using an EGFR tyrosine kinase inhibitor and chemotherapy.
Masubuchi H, Maeno T, Uchida M, Kono S, Suzuki M, Takemura M, Yamaguchi A, Yamaguchi K, Kanbe M, Kitahara S, Hara K, Hara S, Aoki N, Suga T, Kurabayashi M. Masubuchi H, et al. Respir Med Case Rep. 2015 May 23;15:101-5. doi: 10.1016/j.rmcr.2015.05.001. eCollection 2015. Respir Med Case Rep. 2015. PMID: 26236616 Free PMC article.